Inhibition of cardiac effects of noradrenaline by eleven indole alkaloids, two azepinoindoles, quinidine, quindonium, and propranolol.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004558:Electric Stimulation; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D011433:Propranolol / Q000494:pharmacology*; D011802:Quinidine / Q000494:pharmacology*; D011807:Quinolizines / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology; D012849:Sinoatrial Node / Q000187:drug effects
D000470:Alkaloids; D001381:Azepines; D007211:Indoles; D011807:Quinolizines; D012110:Reserpine; D011433:Propranolol; D011802:Quinidine; D009638:Norepinephrine